Comorbidities and psoriasis. Impact on clinical practice;Komorbiditäten und psoriasis: Konsequenzen für die praxis

Hautarzt

Volumn 63, Issue 3, 2012, Pages 202-213

  Gerdes, S ^a   Mrowietz, U ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Co medication; Comorbidity; Obesity; Psoriasis; Therapy

Indexed keywords

ANTIPSORIASIS AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY DISEASE; DERMATOLOGIST; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MENTAL DISEASE; METABOLIC DISORDER; OBESITY; PSORIASIS; STROKE; SYSTEMIC THERAPY;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; COMORBIDITY; COOPERATIVE BEHAVIOR; HUMANS; INTERDISCIPLINARY COMMUNICATION; MENTAL DISORDERS; OBESITY; PATIENT CARE TEAM; PSORIASIS; REFERRAL AND CONSULTATION; SMOKING;

EID: 84863108421     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-011-2230-x     Document Type: Article

References (45)

1. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
2. Armstrong AW, Armstrong EJ, Fuller EN et al (2011) Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol 165(6):1162-1168
3. Armstrong AW, Voyles SV, Armstrong EJ et al (2011) A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 20:544-549
4. Augustin M, Glaeske G, Radtke MA et al (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633-636
5. Boehncke S, Fichtlscherer S, Salgo R et al (2011) Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Arch Dermatol Res 303:381-388
6. Boehncke S, Thaci D, Beschmann H et al (2007) Psoriasis patients show signs of insulin resistance. Br J Dermatol 157:1249-1251 (Pubitemid 350115673)
7. Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011 b) The "psoriatic march": a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303-307
8. Boehncke WH, Buerger C, Boehncke S (2009) Comorbidities in psoriasis vulgaris. Hautarzt 60:116-121
9. Bremmer S, Van Voorhees AS, Hsu S et al (2010) Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 63:1058-1069
10. Cugno M, Ingegnoli F, Gualtierotti R, Fantini F (2010) Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis. Curr Vasc Pharmacol 8:285-292
11. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375:181-183
12. Fortes C, Mastroeni S, Leffondre K et al (2005) Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 141:1580-1584 (Pubitemid 41815850)
13. Gelfand JM, Neimann AL, Shin DB et al (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-1741 (Pubitemid 44547793)
14. Gerdes S, Mrowietz U (2009) Impact of comorbidities on the management of psoriasis. Curr Probl Dermatol 38:21-36
15. Gerdes S, Rostami-Yazdi M, Mrowietz U (2011) Adipokines and psoriasis. Exp Dermatol 20:81-87
16. Gerdes S, Zahl VA, Knopf H et al (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 159:1116-1123
17. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U (2010) Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 220:38-43
18. Gisondi P, Del GM, Di FV et al (2008) Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to lowdose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 88:1242-1247
19. Gisondi P, Farina S, Giordano MV, Girolomoni G (2010) Usefulness of theframingham risk score in patients with chronic psoriasis. Am J Cardiol 106:1754-1757
20. Han C, Lofland JH, Zhao N, Schenkel B (2011) Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol 10:843-850
21. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-986
22. Hossler EW, Maroon MS, Mowad CM (2011) Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 65:198-200
23. Jin Y, Yang S, Zhang F et al (2009) Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol 23:132-137
24. Jin Y, Zhang F, Yang S et al (2008) Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population. J Dermatol Sci 52:123-129
25. Kannan S, Heller MM, Lee ES, Koo JY (2011) The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat [Epub ahead of print]
26. Kirby B, Richards HL, Mason DL et al (2008) Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 158:138-140 (Pubitemid 350221922)
27. McAleer MA, Mason DL, Cunningham S et al (2001) Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress. Br J Dermatol 164:1256-1261
28. Mehta NN, Azfar RS, Shin DB et al (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31:1000-1006
29. Mehta NN, Yu Y, Pinnelas R et al (2011) Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 124:775-776
30. Naldi L, Chatenoud L, Linder D et al (2005) Cigarette smoking, body mass index, and stressful life events as riskfactors for psoriasis: results from an Italian case-control study. J Invest Dermatol 125:61-67 (Pubitemid 40981424)
31. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
32. Paller AS, Siegfried EC, Langley RG et al (2008) Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 358:241-251
33. Patel RV, Shelling ML, Prodanovich S et al (2011) Psoriasis and vascular disease-riskfactors and outcomes: a systematic review of the literature. J Gen Intern Med 26:1036-1049
34. Prodanovich S, Ma F, Taylor JR et al (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:262-267
35. Puig L (2011) Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol 25:1007-1011
36. Reaven GM (2011) The metabolic syndrome: time to get off the merry-go-round? J Intern Med 269:127-136
37. Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040-1047
38. Schmitt JM, Ford DE (2007) Role of depression in quality of life for patients with psoriasis. Dermatology 215:17-2 7 (Pubitemid 46976010)
39. Setty AR, Curhan G, Choi HK (2007) Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 167:1670-1675 (Pubitemid 47280349)
40. Setty AR, Curhan G, Choi HK (2007) Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 120:953-959 (Pubitemid 350011082)
41. Shelton RC, Miller AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91:275-299
42. Wolf N, Quaranta M, Prescott NJ et al (2008) Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 45:114-116 (Pubitemid 351252875)
43. Wormser D, Kaptoge S, Di AE et al (2011) Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377:1085-1095
44. Reich K, Langley RG, Lebwohl M et al (2011) Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol 164:862-872
45. Mrowietz U, Kragballe K, Reich K et al (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303:1-11